Novartis' Alcon Eyed By Lawsuit For Gender Inequality
This article was originally published in Scrip
Novartis is facing another lawsuit regarding gender discrimination – this time from two former employees of the company's Alcon eye-care division. The two women allege in a complaint filed with the US District Court of the Southern District of New York that Alcon "discriminated against them on the basis of their gender" and are seeking $110m in reparations.
You may also be interested in...
Synthetic Genomics, co-founded by genomic pioneer Craig Venter, has been sued by its former intellectual property chief for gender discrimination – a claim that CEO Oliver Fetzer believes to be "without merit."
A handful of former female sales representatives suing Merck & Co. Inc. for gender discrimination, including an alleged bias against employees who took maternity leave, could become a very large group of women now that the lawsuit seeking $250m in damages has been granted conditional certification as a collective action under the Equal Pay Act (EPA).
Two companies in the biopharma space began trading publicly this week, one to pay off debt, the other to fund an early-stage pipeline.